James Emmett Young Insider Profile

4 Followers
James Emmett Young, CFO at TriSalus Life Sciences, holds 66.49K shares in TriSalus Life Sciences (Ticker: TLSI).
tipranks
James Emmett Young

James Emmett Young
TriSalus Life Sciences (TLSI)
CFO

Ranked #47,402 out of 100,956 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+4.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$356K
100.00%
A breakdown of James Emmett Young's holdings

Insider Roles

TriSalus Life Sciences
(TLSI)
CFO
Roles that James Emmett Young holds in companies

Most Profitable Insider Trade

Stock:
TriSalus Life Sciences
(TLSI)
Rating:Informative Buy
Date:Jan 29, 2025 - Today
Return:+9.60%
The most profitable trade made by James Emmett Young

James Emmett Young's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TriSalus Life Sciences
Feb 19, 2025
CFO
Uninformative Buy
$356.38K
Success Rate for
TLSI
1 out of 2 profitable transactions on
TLSI
50%
Average Return for
TLSI
Average return per transaction on
TLSI
+4.65%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 29, 2025
Uninformative Buy
$0.00
-
$0.00
Jan 29, 2025
Informative Buy
$129.60K
-
$5.40
+9.60%
Feb 06, 2025
Informative Buy
$33.90K
-
$5.65
-0.30%
Feb 19, 2025
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see James Emmett Young's performance on stock

James Emmett Young insider profile FAQ

What is the percentage of profitable transactions made by James Emmett Young?
The percentage of profitable transactions made by James Emmett Young is 50%.
    What is the average return per transaction made by James Emmett Young?
    The average return per transaction made by James Emmett Young is 4.60%.
      What stocks does James Emmett Young hold?
      James Emmett Young holds: TLSI stocks.
        What was James Emmett Young’s latest transaction?
        James Emmett Young latest transaction was an Uninformative Buy of ―.
          What was James Emmett Young's most profitable transaction?
          James Emmett Young’s most profitable transaction was an Informative Buy of TLSI stock on January 29, 2025. The return on the trade was 9.60%.
            What is James Emmett Young's role in TriSalus Life Sciences?
            James Emmett Young's role in TriSalus Life Sciences is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.